Latest KFF Health News Stories
More And More, States Are Becoming Battleground For Drug Pricing War
News outlets report on stories related to pharmaceutical pricing.
“If you look at the static effect, it has zero effect on pharmaceutical revenues, because they give the discounts anyway. All of the savings get yanked from hospital revenues and given back to Medicare and beneficiaries,” Peter Bach, the director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes.
Media outlets report on news from California, Connecticut, Massachusetts, Missouri, New Hampshire, New York, Minnesota and Wisconsin.
Diabetes In America, By The Numbers
A new report shows that nearly half of Americans have diabetes or pre-diabetes. In other public health news: diet drinks, vegan diets, plague chasers, telemedicine, readmission rates and Latinos in clinical trials.
Brain Scans Reveal That Some Patients Taking Drugs For Alzheimer’s Don’t Actually Have Disease
A study is looking at how PET scans can help determine what’s Alzheimer’s and what’s some other treatable disease.
Maryland Eyes Expansion Of Needle Exchange Program To Six More Counties
In other news on the epidemic: a 10-year-old Florida boy dies with heroin and fentanyl in his system; new research looks at how drugs impact each person differently; and an Ohio treatment center works to end the overdose cycle.
Lawmakers Meet To Discuss $4B Extension Of VA Choice Program
Funding for the program is set to run out in mid-August.
Trump Could Blow Up The ACA Marketplaces Tomorrow By Stopping Subsidy Payments
The president has threatened to end the payments to insurers before, and now with the failure of the GOP’s proposed bill, the deadline hangs like a guillotine over companies’ heads. “My advice to the plans this morning was, ‘If you get it, cash the check quickly,’” one health care lobbyist who represents insurers said Tuesday.
So What’s Next? Stabilizing Marketplace, Funding CHIP, Curbing Drug Prices And More
Just because the repeal-and-replace legislation failed, doesn’t mean lawmakers can forget about health care.
Getting both parties to the table seems like it may be the only way forward.
Collapse Of Health Plan Sends One Clear Message: Don’t Touch Medicaid
Medicaid became a sticking point in negotiations and shows just how hard it is to roll back entitlement programs in America.
‘If Embarrassment Were Fatal, We’d All Be Dead’: Fallout From Failure Starts To Sink In For GOP
The political ramifications from the collapse of the repeal-and-replace measure — one of the Republicans’ biggest promises — are reverberating through the party.
The Two Senators Willing To Be Labeled ‘Bill Killers’
Sens. Mike Lee (R-Utah) and Jerry Moran (R-Kan.) were the straws that broke the camel’s back.
Health Care Debacle Tarnishes McConnell’s Image As One Of Capitol’s Most Cunning Strategists
The setback raises doubts about the Senate majority leader’s ability to deliver now that Republicans are actually governing.
Trump Brash In The Face Of Defeat: ‘Let Obamacare Fail’
But President Donald Trump is making one more push to get senators to come together on health care. He’ll hold a lunch on Wednesday in hopes of finding a path forward.
GOP Senators Balk At Repeal-Only Proposal: ‘There Is Enough Chaos And Uncertainty Already’
Three Republican senators have already said they won’t vote for a plan that only repeals the Affordable Care Act without coming up with a replacement. But Senate Majority Leader Mitch McConnell (R-Ky.), wanting the lawmakers on record, says he’ll still hold a vote to proceed next week.
Senate’s Proposal Was Doomed From The Start, But Missteps Along The Way Didn’t Help
Media outlets offer tick-tocks of how and why the Senate health care proposal went wrong.
Today’s early morning highlights from the major news organizations.
Opinion writers offer their thoughts on a range of health issues.
Perspectives: The Senate GOP Health Bill Appears To Have Collapsed… But What Could Happen Next?
Editorial pages parse the breaking news late Monday night when two more Republican senators announced their opposition to the measure. What has gone wrong? What paths could go forward? And what issues remain in play?
